QNB Corp director Kenneth Brown buys shares for $3,968 By Investing.com

Micheal

Calidi Biotherapeutics CEO Allan Camaisa sells $16,200 in stock By Investing.com

Following this purchase, Brown holds a total of 150,714 shares in QNB Corp. The company trades at a P/E ratio of 12.6 and has maintained dividend payments for 28 consecutive years. InvestingPro subscribers can access 6 additional key insights about QNBC’s valuation and growth prospects. The company trades at a P/E ratio of 12.6 and has maintained dividend payments for 28 consecutive years. InvestingPro subscribers can access 6 additional key insights about QNBC’s valuation and growth prospects. Following this purchase, Brown holds a total of 150,714 shares in QNB Corp.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Leave a Comment